AAM
Arabesque Asset Management Portfolio holdings
AUM
$296M
1-Year Est. Return
15.19%
1 Year Est. Return
-15.19%
AUM
$296M
AUM Growth
+$90.6M
(+44%)
Holding
144
Top Buys
| 1 | +$3.47M | |
| 2 | +$3.22M | |
| 3 | +$3.19M | |
| 4 |
Cisco
CSCO
|
+$2.69M |
| 5 |
Eaton
ETN
|
+$2.68M |
Top Sells
| 1 | +$2.56M | |
| 2 | +$2.45M | |
| 3 | +$2.33M | |
| 4 |
Willis Towers Watson
WTW
|
+$2.12M |
| 5 |
Weyerhaeuser
WY
|
+$1.91M |
Sector Composition
| 1 | Healthcare | 26.5% |
| 2 | Technology | 19.38% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Industrials | 13.52% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$251B
| $5.51M | 1.86% |
49,653
+22,132
|
|
||
2
Linde
LIN
$197B
| $4.94M | 1.67% |
15,145
+2,381
|
|
||
3
Pfizer
PFE
$143B
| $4.93M | 1.67% |
96,213
+43,810
|
|
||
4
Eli Lilly
LLY
$959B
| $4.81M | 1.63% |
13,143
+5,211
|
|
||
5
Broadcom
AVGO
$1.61T
| $4.79M | 1.62% |
85,590
+40,130
|
|
||
6
AbbVie
ABBV
$401B
| $4.69M | 1.59% |
29,045
+12,883
|
|
||
7
Trane Technologies
TT
$86.4B
| $4.69M | 1.59% |
27,908
+12,638
|
|
||
8
Coca-Cola
KO
$301B
| $4.67M | 1.58% |
73,354
+37,412
|
|
||
9
Union Pacific
UNP
$139B
| $4.5M | 1.52% |
21,755
+11,752
|
|
||
10
Bristol-Myers Squibb
BMY
$110B
| $4.44M | 1.5% |
61,677
+20,212
|
|
||
11
Texas Instruments
TXN
$160B
| $4.43M | 1.5% |
26,840
+13,196
|
|
||
12
TJX Companies
TJX
$172B
| $4.31M | 1.46% |
54,145
+29,938
|
|
||
13
Johnson & Johnson
JNJ
$497B
| $4.26M | 1.44% |
24,103
+10,073
|
|
||
14
O'Reilly Automotive
ORLY
$76.8B
| $4.13M | 1.4% |
73,365
-3,270
|
|
||
15
Amgen
AMGN
$176B
| $4.09M | 1.38% |
15,556
+4,547
|
|
||
16
Abbott
ABT
$218B
| $4.07M | 1.38% |
37,035
+13,199
|
|
||
17
AutoZone
AZO
$56.3B
| $4.01M | 1.36% |
1,628
-120
|
|
||
18
Thermo Fisher Scientific
TMO
$213B
| $3.94M | 1.33% |
7,160
+3,189
|
|
||
19
Danaher
DHR
$159B
| $3.86M | 1.31% |
16,398
+5,701
|
|
||
20
Mondelez International
MDLZ
$70.3B
| $3.84M | 1.3% |
57,613
+22,365
|
|
||
21
Regeneron Pharmaceuticals
REGN
$80.7B
| $3.75M | 1.27% |
5,199
+1,390
|
|
||
22
Qualcomm
QCOM
$188B
| $3.57M | 1.21% |
32,437
+15,351
|
|
||
23
Procter & Gamble
PG
$338B
| $3.56M | 1.2% |
23,494
+7,331
|
|
||
24
Gilead Sciences
GILD
$154B
| $3.53M | 1.2% |
41,171
+4,390
|
|
||
25
Enphase Energy
ENPH
$4.35B
| $3.47M | 1.17% |
+13,084
|
|